Enliven Therapeutics Inc (NASDAQ: ELVN) is -26.53% lower on its value in year-to-date trading and has touched a low of $13.30 and a high of $30.03 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELVN stock was last observed hovering at around $16.07 in the last trading session, with the day’s gains setting it 0.46%.
Currently trading at $16.53, the stock is -11.52% and -17.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing 2.86% at the moment leaves the stock -28.68% off its SMA200. ELVN registered -11.56% loss for a year compared to 6-month loss of -40.58%. The firm has a 50-day simple moving average (SMA 50) of $20.1082 and a 200-day simple moving average (SMA200) of $23.178225.
The stock witnessed a -20.87% gain in the last 1 month and extending the period to 3 months gives it a -24.83%, and is 10.87% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.78% over the week and 9.99% over the month.
Enliven Therapeutics Inc (ELVN) has around 62 employees, a market worth around $810.04M and $0.00M in sales. Distance from 52-week low is 24.29% and -44.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.73%).
The EPS is expected to shrink by -16.22% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
172.0 institutions hold shares in Enliven Therapeutics Inc (ELVN), with institutional investors hold 109.84% of the company’s shares. The shares outstanding are 48.94M, and float is at 31.69M with Short Float at 22.93%. Institutions hold 102.84% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 7.96 million shares valued at $186.01 million. The investor’s holdings represent 16.5565 of the ELVN Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 5.69 million shares valued at $133.08 million to account for 11.8452 of the shares outstanding. The other top investors are VR ADVISER, LLC which holds 4.03 million shares representing 8.3751 and valued at over $94.1 million, while COMMODORE CAPITAL LP holds 8.2647 of the shares totaling 3.97 million with a market value of $92.85 million.
Enliven Therapeutics Inc (ELVN) Insider Activity
Still, SEC filings show that on Apr 14 ’25, Patel Anish (Member of immediate family of ) Proposed Sale 2,010 shares at an average price of $16.51 for $33185.0. The insider now directly holds shares of Enliven Therapeutics Inc (ELVN).
